TruBridge Delays 2025 Year-End Earnings Release
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 16 2026
0mins
Should l Buy TBRG?
Source: Newsfilter
- Earnings Release Postponed: TruBridge has announced the postponement of its fourth quarter and year-end 2025 earnings release originally scheduled for March 16, 2026, to allow for the completion of year-end audit procedures, which may impact investor confidence.
- Financial Statement Errors: Errors were identified in the consolidated financial statements for 2024 and several quarters of 2025, primarily related to revenue recognition and software development costs, necessitating revisions to the 2024 financial statements, although the company believes these errors do not materially affect its financial position.
- Internal Control Deficiencies: TruBridge has identified deficiencies in internal controls over financial reporting, which management has deemed material weaknesses as of December 31, 2025, potentially affecting future financial transparency and compliance, necessitating strengthened internal control processes.
- Future Outlook: TruBridge expects to file its 2025 Form 10-K within the 15-day extension period granted by the SEC; despite facing audit delays, the company is committed to improving its financial reporting processes to ensure future compliance and accuracy.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TBRG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TBRG
Wall Street analysts forecast TBRG stock price to rise
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 14.600
Low
21.00
Averages
22.00
High
23.00
Current: 14.600
Low
21.00
Averages
22.00
High
23.00
About TBRG
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ademi LLP Investigates TruBridge for Possible Securities Fraud
- Investigation Background: Ademi LLP is investigating TruBridge for possible securities fraud due to potentially inaccurate statements regarding its financial statements, business operations, and prospects, which may undermine investor confidence.
- Financial Statement Issues: The investigation focuses on whether TruBridge's claims about revenue accounting, software development costs, and share-based payments were accurate, potentially exposing investors to financial losses.
- Legal Consequences: Should the investigation confirm fraudulent activities by TruBridge, it could lead to class-action lawsuits, further impacting the company's stock price and market reputation, prompting investors to closely monitor developments.
- Investor Action: Ademi LLP offers a no-cost opportunity for affected investors to join the investigation, emphasizing its commitment to protecting investor rights and encouraging those impacted to reach out for more information.
See More
AGH Integrates Microsoft Dragon Copilot to Enhance Patient Care
- Documentation Burden Reduction: AGH's integration of Microsoft Dragon Copilot allows physicians to report a 50%-75% reduction in documentation time, significantly alleviating the clinical documentation burden and enabling healthcare providers to focus more on patient care, thereby enhancing service quality.
- Real-Time Translation Feature: The system supports real-time communication with non-English-speaking patients, ensuring they can converse comfortably in their own language with the care team, which is particularly significant in multilingual communities and enhances the overall patient experience.
- Multi-Party Recognition Technology: Dragon Copilot distinguishes between different individuals in the room, such as doctors, patients, and caregivers, automatically generating accurate transcripts of conversations, which ensures the completeness and accuracy of clinical information and improves the quality of medical records.
- Leader in Digital Transformation: AGH's implementation of this technology showcases its leadership in the digital transformation of rural healthcare, emphasizing the critical role of technology in enhancing clinical efficiency and patient experience, further solidifying its core position in community healthcare.
See More
TruBridge Under Investigation for Possible Securities Law Violations
- Delayed Financial Reporting: On March 16, 2026, TruBridge disclosed its inability to timely file its 2025 Annual Report due to identified errors in the consolidated financial statements for 2024 and out-of-period errors for multiple quarters in 2025, primarily related to revenue accounting, software development costs, and share-based payments, which may undermine investor confidence.
- Significant Stock Price Drop: Following this announcement, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share on March 17, 2026, directly impacting investors' asset values and reflecting market concerns over the company's financial transparency.
- Legal Investigation Initiated: The Law Offices of Howard G. Smith announced an investigation into TruBridge on behalf of investors to pursue potential claims for losses, indicating heightened scrutiny over the company's compliance and financial reporting, which could lead to further legal actions.
- Investor Rights Protection: The law firm is urging affected investors to reach out for loss recovery, emphasizing the importance of actively protecting investor rights during financial distress, which may encourage more investors to engage in legal actions seeking compensation.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) due to potential issuance of materially misleading business information, which may expose shareholders to securities claims.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely file its Annual Report for the fiscal year ended December 31, 2025, citing the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and governance.
- Legal Action Outlook: Investors may join the prospective class action without any out-of-pocket fees through a contingency fee arrangement, as Rosen Law Firm prepares to seek recovery of investor losses, emphasizing its commitment to protecting investor rights.
See More
TruBridge Faces Investor Lawsuit Investigation
- Legal Investigation Initiated: Bragar Eagel & Squire, P.C. is investigating TruBridge, Inc. (NASDAQ:TBRG) for potential violations of federal securities laws and other unlawful business practices, indicating significant legal risks that could impact the company's market reputation.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 revealing its inability to timely submit its Annual Report for the fiscal year 2025 due to identified errors in prior financial statements, which may lead to decreased investor confidence in the company's financial transparency.
- Significant Stock Price Drop: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's future performance and stability.
- Investor Rights Advocacy: Bragar Eagel & Squire encourages affected investors to contact their attorneys to discuss legal rights, demonstrating a proactive approach to protecting investor interests, which may influence the trajectory of future legal proceedings.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) due to potential issuance of materially misleading business information, exposing shareholders to possible securities claims.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely file its Annual Report for the fiscal year ending December 31, 2025, citing the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Decline: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share on March 17, 2026, reflecting market concerns regarding the company's financial transparency and credibility.
- Class Action Preparation: The Rosen Law Firm is preparing a class action to seek compensation for investor losses, allowing participation without upfront fees, highlighting the uncertainty surrounding TruBridge's future financial health.
See More
Ademi LLP Investigates TruBridge for Possible Securities Fraud
- Investigation Background: Ademi LLP is investigating TruBridge for possible securities fraud due to potentially inaccurate statements regarding its financial statements, business operations, and prospects, which may undermine investor confidence.
- Financial Statement Issues: The investigation focuses on whether TruBridge's claims about revenue accounting, software development costs, and share-based payments were accurate, potentially exposing investors to financial losses.
- Legal Consequences: Should the investigation confirm fraudulent activities by TruBridge, it could lead to class-action lawsuits, further impacting the company's stock price and market reputation, prompting investors to closely monitor developments.
- Investor Action: Ademi LLP offers a no-cost opportunity for affected investors to join the investigation, emphasizing its commitment to protecting investor rights and encouraging those impacted to reach out for more information.
See More
AGH Integrates Microsoft Dragon Copilot to Enhance Patient Care
- Documentation Burden Reduction: AGH's integration of Microsoft Dragon Copilot allows physicians to report a 50%-75% reduction in documentation time, significantly alleviating the clinical documentation burden and enabling healthcare providers to focus more on patient care, thereby enhancing service quality.
- Real-Time Translation Feature: The system supports real-time communication with non-English-speaking patients, ensuring they can converse comfortably in their own language with the care team, which is particularly significant in multilingual communities and enhances the overall patient experience.
- Multi-Party Recognition Technology: Dragon Copilot distinguishes between different individuals in the room, such as doctors, patients, and caregivers, automatically generating accurate transcripts of conversations, which ensures the completeness and accuracy of clinical information and improves the quality of medical records.
- Leader in Digital Transformation: AGH's implementation of this technology showcases its leadership in the digital transformation of rural healthcare, emphasizing the critical role of technology in enhancing clinical efficiency and patient experience, further solidifying its core position in community healthcare.
See More
TruBridge Under Investigation for Possible Securities Law Violations
- Delayed Financial Reporting: On March 16, 2026, TruBridge disclosed its inability to timely file its 2025 Annual Report due to identified errors in the consolidated financial statements for 2024 and out-of-period errors for multiple quarters in 2025, primarily related to revenue accounting, software development costs, and share-based payments, which may undermine investor confidence.
- Significant Stock Price Drop: Following this announcement, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share on March 17, 2026, directly impacting investors' asset values and reflecting market concerns over the company's financial transparency.
- Legal Investigation Initiated: The Law Offices of Howard G. Smith announced an investigation into TruBridge on behalf of investors to pursue potential claims for losses, indicating heightened scrutiny over the company's compliance and financial reporting, which could lead to further legal actions.
- Investor Rights Protection: The law firm is urging affected investors to reach out for loss recovery, emphasizing the importance of actively protecting investor rights during financial distress, which may encourage more investors to engage in legal actions seeking compensation.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) due to potential issuance of materially misleading business information, which may expose shareholders to securities claims.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely file its Annual Report for the fiscal year ended December 31, 2025, citing the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and governance.
- Legal Action Outlook: Investors may join the prospective class action without any out-of-pocket fees through a contingency fee arrangement, as Rosen Law Firm prepares to seek recovery of investor losses, emphasizing its commitment to protecting investor rights.
See More
TruBridge Faces Investor Lawsuit Investigation
- Legal Investigation Initiated: Bragar Eagel & Squire, P.C. is investigating TruBridge, Inc. (NASDAQ:TBRG) for potential violations of federal securities laws and other unlawful business practices, indicating significant legal risks that could impact the company's market reputation.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 revealing its inability to timely submit its Annual Report for the fiscal year 2025 due to identified errors in prior financial statements, which may lead to decreased investor confidence in the company's financial transparency.
- Significant Stock Price Drop: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's future performance and stability.
- Investor Rights Advocacy: Bragar Eagel & Squire encourages affected investors to contact their attorneys to discuss legal rights, demonstrating a proactive approach to protecting investor interests, which may influence the trajectory of future legal proceedings.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) due to potential issuance of materially misleading business information, exposing shareholders to possible securities claims.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely file its Annual Report for the fiscal year ending December 31, 2025, citing the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Decline: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share on March 17, 2026, reflecting market concerns regarding the company's financial transparency and credibility.
- Class Action Preparation: The Rosen Law Firm is preparing a class action to seek compensation for investor losses, allowing participation without upfront fees, highlighting the uncertainty surrounding TruBridge's future financial health.
See More
